Role of Ubiquitin in Cardiovascular System

泛素在心血管系统中的作用

基本信息

  • 批准号:
    8645689
  • 负责人:
  • 金额:
    $ 36.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-07-15 至 2016-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The N-end rule pathway is one ubiquitin proteolytic pathway that relates the in vivo half-life of a protein to the identity of its N-terminal residue. Conjugation of arginine (Arg) from Arg-tRNAArg to N-terminal aspartate (Asp), glutamate (Glu), or cysteine (Cys) is part of this proteolytic pathway in that it can lead to ubiquitination of the resulting Arg-conjugated proteins. We have previously identified the mammalian Ate1 gene encoding Arg-transferases responsible for all known protein arginylation activities and have shown that Ate1-/- embryos die owing to various cardiovascular defects including ventricular hypoplasia, ventricular septal defect, and late angiogenesis. These results suggest that Ate1-dependent proteolysis of unknown substrate(s) is a crucial regulatory mechanism for myocardial growth and blood vessel integrity/maturation. However, the exact nature of the cardiovascular defects and the underlying molecular mechanisms remain elusive. Genomewide functional proteomic approach led us to identify a set of cardiovascular regulators (Rgs4, Rgs5, and Rgs16) as substrates of Ate1-dependent arginylation that may underlie, at least partially, Ate1-dependent cardiovascular homeostasis. Notably, Rgs4 and Rgs5 are GTPase-activating proteins (GAP) that act as negative regulators of GPCR-coupled Ga subunits and have been implicated as important regulators of Gq/Gi-activated signaling for myocardial growth and vascular maturation/integrity, respectively. Biochemical analyses showed that degradation of these substrates depends on the Cys2 residue as a degradation determinant, which is exposed to the N-terminus through cleavage of N-terminal Met by Met aminopeptidases. In the presence of sufficient oxygen (O2) and nitric oxide (NO), N-terminal Cys2 appears to be oxidized to CysO2 to create a structural homolog of Asp, an arginylation-permissive residue. The N-terminal Arg residue of arginylated RGS proteins is subsequently bound by specific E3 ligases whose identities remain unclear. Using an affinity-based proteomic approach, we isolated a set of E3 family (named Ubr1 through Ubr7) and demonstrated that Ubr1, Ubr2, and Ubr4 are the major E3s specific for protein arginylation and that Ubr1-/-Ubr2-/- and Ubr4-/- embryos die of cardiovascular defects. Based on these results, we hypothesize that the functions of Rgs4, Rgs5, and Rgs16 are modulated through the MetAPs-O2/NO-Ate1-Ubr proteolytic cascade. In Aim 1, we will characterize the physiological function of Ate1-dependent arginylation in cardiovascular development and signaling using tissue-specific Ate1 knockout mice in combination with transgenic mice overexpressing Gq in the heart. In Aim 2, to understand the molecular principles underlying Ate1-dependent cardiovascular development, we will characterize arginylation-dependent turnover and cotranslational modifications of Cys2 of Rgs4 and Rgs5. In Aim 3, as part of our long-term efforts to characterize ubiquitin ligases specific of arginylated substrates, we will characterize cardiovascular development of mice lacking Ubr4, a newly identified recognition component downstream of protein arginylation. 1
描述(由申请人提供):N-末端规则途径是一种泛素蛋白水解途径,其将蛋白质的体内半衰期与其N-末端残基的身份联系起来。精氨酸(Arg)从Arg-tRNAArg到N-末端天冬氨酸(Asp)、谷氨酸(Glu)或半胱氨酸(Cys)的缀合是该蛋白水解途径的一部分,因为它可以导致所得Arg缀合蛋白的泛素化。我们以前已经确定了哺乳动物Ate 1基因编码的精氨酸转移酶负责所有已知的蛋白质腺苷酸化活动,并已表明,Ate 1-/-胚胎死亡,由于各种心血管缺陷,包括心室发育不全,室间隔缺损,和晚期血管生成。这些结果表明,Ate 1依赖的未知底物的蛋白水解是心肌生长和血管完整性/成熟的重要调控机制。然而,心血管缺陷的确切性质和潜在的分子机制仍然难以捉摸。全基因组功能蛋白质组学方法使我们确定了一组心血管调节因子(Rgs 4,Rgs 5和Rgs 16)作为Ate 1依赖性腺苷酸化的底物,这可能是Ate 1依赖性心血管稳态的至少部分基础。值得注意的是,Rgs 4和Rgs 5是GTP酶激活蛋白(GAP),其充当GPCR偶联的Ga亚基的负调节剂,并且已经被认为分别是心肌生长和血管成熟/完整性的Gq/Gi激活信号传导的重要调节剂。生化分析表明,这些底物的降解依赖于Cys 2残基作为降解决定簇,其通过由Met氨基肽酶切割N-末端Met而暴露于N-末端。在足够的氧气(O2)和一氧化氮(NO)的存在下,N-末端Cys 2似乎被氧化为CysO 2,以创建一个结构同源物的天冬氨酸,一个允许的残基。N-末端精氨酸残基的乙酰化RGS蛋白随后结合的特定E3连接酶的身份仍然不清楚。利用基于亲和性的蛋白质组学方法,我们分离了一组E3家族(命名为Ubr 1至Ubr 7),并证明Ubr 1,Ubr 2和Ubr 4是蛋白质乙酰化的主要E3,Ubr 1-/-Ubr 2-/-和Ubr 4-/-胚胎死于心血管缺陷。基于这些结果,我们假设Rgs 4、Rgs 5和Rgs 16的功能通过MetAPs-O2/NO-Ate 1-Ubr蛋白水解级联反应来调节。在目标1中,我们将使用组织特异性Ate 1基因敲除小鼠与心脏中过表达Gq的转基因小鼠组合来表征Ate 1依赖性腺苷酸化在心血管发育和信号传导中的生理功能。在目标2中,为了了解Ate 1依赖性心血管发展的分子原理,我们将表征Rgs 4和Rgs 5的Cys 2的磷酸化依赖性周转和共翻译修饰。在目标3中,作为我们长期努力的一部分,以表征泛素连接酶特异性的β-淀粉酰化底物,我们将表征心血管发育的小鼠缺乏Ubr 4,一个新发现的识别组件下游的蛋白β-淀粉酰化。1

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YONG TAE KWON其他文献

YONG TAE KWON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YONG TAE KWON', 18)}}的其他基金

Proteomics of Ubiquitin-Dependent N-End Rule Pathway
泛素依赖性 N 端规则途径的蛋白质组学
  • 批准号:
    7350248
  • 财政年份:
    2006
  • 资助金额:
    $ 36.45万
  • 项目类别:
Proteomics of Ubiquitin-Dependent N-End Rule Pathway
泛素依赖性 N 端规则途径的蛋白质组学
  • 批准号:
    7577417
  • 财政年份:
    2006
  • 资助金额:
    $ 36.45万
  • 项目类别:
Proteomics of Ubiquitin-Dependent N-End Rule Pathway
泛素依赖性 N 端规则途径的蛋白质组学
  • 批准号:
    7037956
  • 财政年份:
    2006
  • 资助金额:
    $ 36.45万
  • 项目类别:
Role of Ubiquitin in Cardiovascular System
泛素在心血管系统中的作用
  • 批准号:
    7470589
  • 财政年份:
    2006
  • 资助金额:
    $ 36.45万
  • 项目类别:
Role of Ubiquitin in Cardiovascular System
泛素在心血管系统中的作用
  • 批准号:
    7256969
  • 财政年份:
    2006
  • 资助金额:
    $ 36.45万
  • 项目类别:
Role of Ubiquitin in Cardiovascular System
泛素在心血管系统中的作用
  • 批准号:
    8828754
  • 财政年份:
    2006
  • 资助金额:
    $ 36.45万
  • 项目类别:
Role of Ubiquitin in Cardiovascular System
泛素在心血管系统中的作用
  • 批准号:
    8442244
  • 财政年份:
    2006
  • 资助金额:
    $ 36.45万
  • 项目类别:
Role of Ubiquitin in Cardiovascular System
泛素在心血管系统中的作用
  • 批准号:
    8290857
  • 财政年份:
    2006
  • 资助金额:
    $ 36.45万
  • 项目类别:
Role of Ubiquitin in Cardiovascular System
泛素在心血管系统中的作用
  • 批准号:
    7141372
  • 财政年份:
    2006
  • 资助金额:
    $ 36.45万
  • 项目类别:
Role of Ubiquitin in Cardiovascular System
泛素在心血管系统中的作用
  • 批准号:
    7873043
  • 财政年份:
    2006
  • 资助金额:
    $ 36.45万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 36.45万
  • 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 36.45万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 36.45万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了